A study by Li et al. examined changes in the protein expression of CAT at various stages of MASLD; while it revealed unchanged CAT expression in simple steatosis, a considerable reduction in fatty as well as non-fatty MASH liver samples was shown (Li et al. 2018). The gene discussed is CAT; the disease is metabolic dysfunction-associated steatotic liver disease.